欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0921/001
药品名称Glucose-Na-K Baxter
活性成分
    • glucose 50.0 g
    • magnesium chloride hexahydrate 300.0 mg
    • potassium chloride 1.5 g
    • sodium acetate 3.13 g
    • sodium chloride 1.0 g
剂型Solution for infusion
上市许可持有人Baxter Medical AB Sweden
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Denmark (DK)
    • France (FR)
    • Netherlands (NL)
    • Portugal (PT)
    • Cyprus (CY)
      Stabilyte 50mg/ml Solution for Infusion
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Finland (FI)
    • Bulgaria (BG)
      Stabilyte
    • Malta (MT)
    • Slovenia (SI)
    • Romania (RO)
      GNAK 50 mg/ml soluție perfuzabilă
    • Poland (PL)
    • Spain (ES)
    • Italy (IT)
    • Czechia (CZ)
      Stabilyte 50 mg/ml Solution for Infusion
    • Slovakia (SK)
    • Croatia (HR)
    • Greece (GR)
    • Germany (DE)
      Maintelyte 50 mg/ml Infusionslösung
许可日期2009/09/01
最近更新日期2024/03/19
药物ATC编码
    • B05BB02 electrolytes with carbohydrates
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic Art 10 a Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase